Here's What We Think About Daxor Corporation's (NYSEMKT:DXR) CEO Pay
In 2016 Michael Feldschuh was appointed CEO of Daxor Corporation (NYSEMKT:DXR). First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth that the business demonstrates. And finally - as a second measure of performance - we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO.
View our latest analysis for Daxor
How Does Michael Feldschuh's Compensation Compare With Similar Sized Companies?
According to our data, Daxor Corporation has a market capitalization of US$36m, and paid its CEO total annual compensation worth US$100k over the year to December 2018. Notably, the salary of US$100k is the vast majority of the CEO compensation. We examined a group of similar sized companies, with market capitalizations of below US$200m. The median CEO total compensation in that group is US$526k.
This would give shareholders a good impression of the company, since most similar size companies have to pay more, leaving less for shareholders. Though positive, it's important we delve into the performance of the actual business.
You can see, below, how CEO compensation at Daxor has changed over time.
Is Daxor Corporation Growing?
On average over the last three years, Daxor Corporation has grown earnings per share (EPS) by 13% each year (using a line of best fit). In the last year, its revenue is down 22%.
Overall this is a positive result for shareholders, showing that the company has improved in recent years. Revenue growth is a real positive for growth, but ultimately profits are more important. It could be important to check this free visual depiction of what analysts expect for the future.
Has Daxor Corporation Been A Good Investment?
With a total shareholder return of 18% over three years, Daxor Corporation shareholders would, in general, be reasonably content. But they would probably prefer not to see CEO compensation far in excess of the median.
In Summary...
It appears that Daxor Corporation remunerates its CEO below most similar sized companies.
Since the business is growing, many would argue this suggests the pay is modest. While returns over the last few years haven't been top notch, there is nothing to suggest to us that Michael Feldschuh is overcompensated. It's good to see reasonable payment of the CEO, even while the business improves. But for me, it's even better if insiders are also buying shares with their own cold, hard, cash. So you may want to check if insiders are buying Daxor shares with their own money (free access).
Important note: Daxor may not be the best stock to buy. You might find something better in this list of interesting companies with high ROE and low debt.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.
